The latest closing stock price for Oramed Pharmaceuticals as of September 18, 2024 is 2.42.
An investor who bought $1,000 worth of Oramed Pharmaceuticals stock at the IPO in 2007 would have $-694 today, roughly -1 times their original investment - a -6.74% compound annual growth rate over 17 years.
The all-time high Oramed Pharmaceuticals stock closing price was 29.75 on November 08, 2021.
The Oramed Pharmaceuticals 52-week high stock price is 3.67, which is 51.7% above the current share price.
The Oramed Pharmaceuticals 52-week low stock price is 1.67, which is 31% below the current share price.
The average Oramed Pharmaceuticals stock price for the last 52 weeks is 2.44.
An investor who bought $1,000 worth of Oramed Pharmaceuticals stock at the IPO in 2007 would have $-694 today, roughly -1 times their original investment - a -6.74% compound annual growth rate over 17 years.
The all-time high Oramed Pharmaceuticals stock closing price was 29.75 on November 08, 2021.
The Oramed Pharmaceuticals 52-week high stock price is 3.67, which is 51.7% above the current share price.
The Oramed Pharmaceuticals 52-week low stock price is 1.67, which is 31% below the current share price.
The average Oramed Pharmaceuticals stock price for the last 52 weeks is 2.44.